Synthetic vaccines: the role of adjuvants in immune targeting.
about
Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidatesIncreasing the antigenicity of synthetic tumor-associated carbohydrate antigens by targeting Toll-like receptorsDesign and synthesis of potent Quillaja saponin vaccine adjuvantsChemical synthesis and proinflammatory responses of monophosphoryl lipid A adjuvant candidates.Robust immune responses elicited by a fully synthetic three-component vaccine.Mucosal adjuvant properties of the Shigella invasin complexSynergistic induction of interferon α through TLR-3 and TLR-9 agonists identifies CD21 as interferon α receptor for the B cell responseSynthesis and preclinical evaluation of QS-21 variants leading to simplified vaccine adjuvants and mechanistic probesAiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates.The design and implementation of the immune epitope database and analysis resource.Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines.Synthesis of QS-21-xylose: establishment of the immunopotentiating activity of synthetic QS-21 adjuvant with a melanoma vaccine.TLR ligands that stimulate the metabolism of vitamin D3 in activated murine dendritic cells can function as effective mucosal adjuvants to subcutaneously administered vaccines.Gold nanoparticle mediated cancer immunotherapyMechanisms of tumor-induced T cell immune suppression and therapeutics to counter those effects.Formulation of meningococcal capsular polysaccharide vaccine-loaded microparticles with robust innate immune recognition.Towards a fully synthetic MUC1-based anticancer vaccine: efficient conjugation of glycopeptides with mono-, di-, and tetravalent lipopeptides using click chemistry.c-Jun N-terminal kinase 1 is required for Toll-like receptor 1 gene expression in macrophages.
P2860
Q27489000-08852CCC-410A-434B-A6B3-064C587E9AF3Q33591916-DD9D04FB-2369-473F-9AD5-4162A16E1E39Q33645835-476BEFA0-B158-4D27-83F9-720A2B693022Q33714195-1F41F412-35B3-4413-B098-A70EBD0FA4EFQ33721005-8219547D-116F-4E83-A035-46F89F034BE2Q34601845-718860F6-82A2-4021-888E-A32AE9E32995Q34629175-70909764-04D4-4D77-A607-E1C8FD2D9375Q36216866-3F884527-1005-4348-92D9-6D8BCB218CFBQ36600380-A837DB9B-CB8F-41F1-ACF5-F58C380509C2Q36659226-6B72C381-5506-4AC8-9EAC-B4CF51E78919Q36802325-920D24AE-113A-457C-8537-AAC72D9CA4DAQ37014879-CB146A47-97F5-429D-A346-4AF8BECDD797Q37077316-EB15F03C-FDA3-4686-BB68-388347444DE4Q37666077-A6B5CAFE-B9F5-4A29-A9AB-F7168F655F8EQ38336989-BB7B582C-07F0-4F72-AE60-D40224A08830Q39338512-5C5920FE-E501-47C0-A833-C7C157A2546CQ39549229-3FF5F806-B18E-48E5-AE8D-079A6D1B68CEQ40100429-A1CFF781-AC92-478F-B557-F989CC6DD134
P2860
Synthetic vaccines: the role of adjuvants in immune targeting.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Synthetic vaccines: the role of adjuvants in immune targeting.
@ast
Synthetic vaccines: the role of adjuvants in immune targeting.
@en
type
label
Synthetic vaccines: the role of adjuvants in immune targeting.
@ast
Synthetic vaccines: the role of adjuvants in immune targeting.
@en
prefLabel
Synthetic vaccines: the role of adjuvants in immune targeting.
@ast
Synthetic vaccines: the role of adjuvants in immune targeting.
@en
P356
P1476
Synthetic vaccines: the role of adjuvants in immune targeting.
@en
P2093
R Rao Koganty
Zi-Hua Jiang
P304
P356
10.2174/0929867033457340
P577
2003-08-01T00:00:00Z